Abstract
A double-blind withdrawal trial in 41 chronic schizophrenic outpatients was carried out during 6 months. Depot neuroleptics (fluphenazine decanoate or flupenthixol decanoate) were compared with placebo to evaluate clinical and neurological effects during continued therapy and during withdrawal. The drugs were significantly more effective than placebo in preventing relapse and rehospitalization. In the placebo group 62% relapsed compared to 27% in the drug group. There was a weak and nonsignificant tendency to a higher relapse frequency in the flupenthixol group compared to the fluphenazine group. After withdrawal for 6 months, plasma levels for fluphenazine were detectable. Plasma levels for flupenthixol were not detectable after 9 weeks of withdrawal. The differences in the plasma levels may possibly explain the difference in relapse rate between the two depot neuroleptics. Furthermore, it was found that the patients who relapsed during fluphenazine treatment had a significantly lower plasma level of the drug than patients who did not relapse during treatment. The results from this study provide some information on the therapeutic levels of fluphenazine and flupenthixol in schizophrenic patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agrup-Andersson L, Bengtsson LÅ, Erlandsson K, Gottfries CG, Witzell-Östlund G (1974) Flupenthixol decanoate: Controlled investigation concerning dosage. Acta Psychiatr Scand (Suppl) 255:7–14
Andrews P, Hall JN, Snaith RP (1976) A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients. Br J Psychiatry 128: 451–455
Armitage P (1971) Statistical methods in medical research. Oxford University Press, London Edinburgh Melbourne
Åsberg M, Montgomery SA, Schalling D, Sedvall G (1978) Comprehensive psychopathological rating scale. Acta Psychiatr Scand (Suppl) 271:1–81
Ayd FJ (1975) The depot fluphenazine: A reappraisal after 10 years clinical experience. Am J Psychiatry 132:491–500
Davis JM (1975) Overview: Maintenance therapy in psychiatry. I. Schizophrenia. Am J Psychiatry 132:1237–1245
Gottfries CG (1971) Flupenthixol and trifluphenazine: A double-blind investigation in the treatment of schizophrenics. Br J Psychiatry 119:547–548
Hansen LB, Larsen N-E, Gulmann N (1982) Dose-response-relationships of perphenazine in the treatment of acute psychoses (in press)
Hirsch SR, Gaind R, Rohde PD, Stevens, BC, Wing JK (1973) Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: Double-blind placebo trial. Br Med J 1:633–637
Jørgensen A (1978) A sensitive and specific radioimmunoassay for cis(Z)-flupenthixol in human serum. Life Sci 23:1533–1542
Kane JM, Rifkin A, Quitkin F, Navak D, Saraf K, Ramos-Lorenzi JR, Klein DF, Sachar EJ (1979) Low-dose fluphenazine decanoate in maintenance treatment of schizophrenia. Psychiatry Res 1:341–348
Nasrallah HA, rivera-Calimlim L, Rogol AD, et al. (1978) Fluphenazine decanoate: Plasma concentrations and clinical response. Psychopharmacol Bull 14:46–47
Prien RF, Cole JO, Belkin NF (1968) Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication. Br J Psychiatry 115:679–686
Simpson GM, Pi EH (1980) Pharmacokinetics of antipsychotic agents. Abstracts of the 12th CINP Congress, Göteborg
Sjöqvist F (1981) General issues related to age and the pharmacology of psychoactive drugs. In: Raskin A, Robinson D, Levine J (eds) Age and the pharmacology of psychoactive drugs. Elsevier, New York, pp 195–204
Smith RC, Crayton J, Dekirmenjian H, Klass D, Davis JM (1979) Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients. Arch Gen Psychiatry 36:579–584
Svendsen O, Aaes-Jørgensen T (1979) Studies on the fate of vegetable oil after intramuscular injection into experimental animals. Acta Pharmacol Toxicol (Copenh) 45:352–378
Wiles DH, Franklin M (1978) Radioimmunoassay for fluphenazine in human plasma. Br J Clin Pharmacol 5:265–268
Wistedt B, Wiles D, Kolakowska T (1981) Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics. Lancet I:1163
Wistedt B (1981) A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients. Acta Psychiatr Scand 64:65–84
Woggon B (1979) Neuroleptika-Absetzversuche bei chronisch schizophrenen Patienten. I. Literaturzusammenfassung. Int Pharmacopsychiatry 14:34–56
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wistedt, B., Jørgensen, A. & Wiles, D. A depot neuroleptic withdrawal study. Psychopharmacology 78, 301–304 (1982). https://doi.org/10.1007/BF00433729
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433729